Wang JH, Lin G, Yan ZP, Wang XL, Cheng JM, Li MQ. Stage II surgical resection of hepatocellular carcinoma after TAE: a report of 38 cases. World J Gastroenterol 1998; 4(2): 133-136 [PMID: 11819256 DOI: 10.3748/wjg.v4.i2.133]
Corresponding Author of This Article
Dr. Jian-Hua Wang, Department of Radiology, Zhongshan Hospital of Shanghai Medical University, Shanghai 200032, China
Article-Type of This Article
Original Articles
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jian-Hua Wang, Gui Lin, Zhi-Ping Yan, Xiao-Lin Wang, Jie-Ming Cheng, Mao-Quan Li, Department of Radiology, Zhongshan Hospital of Shanghai Medical University, Shanghai 200032, China
Jian-Hua Wang, male, born on 1953-01-07 in Huainan City, Anhui Province, Han nationality, graduated from the Graduate School of Shanghai Medical University as M.D. in 1989, professor of radiology, majoring interventional radiology, having 23 papers published. Presented at the 1st Asian-Pacific Congress of Cardivascular & Interventional Radiology, Seoul, 24-27 May, 1993
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Jian-Hua Wang, Department of Radiology, Zhongshan Hospital of Shanghai Medical University, Shanghai 200032, China
Received: September 2, 1997 Revised: December 20, 1997 Accepted: February 20, 1998 Published online: April 15, 1998
Abstract
AIM: To evaluate the curative effect of stage II surgical resection of hepatocellular carcinoma after TAE.
METHODS: Thirty-eight patients with unresectable hepatocellular carcinoma were treated by transcatheter arterial embolization (TAE). When the sizes of tumors were markedly reduced after TAE, stage II surgical resections were performed.
RESULTS: Before TAE, the diameters of tumors were 12.84 cm ± 4.87 cm (x ± s), but reduced to 5.12 cm ± 1.82 cm (x ± s) after TAE (P < 0.001). Pathologic examination of the resected specimens revealed obvious necrosis in most cases. After surgery, 26 patients were alive, with the longest survival of 96 months, twelve died and 10 had tumor recurrence.
CONCLUSION: Patients in moderate and advanced stages of hepatocellular carcinoma after TAE should be treated surgically, but the indication must be controlled strictly.
